Clara Höbart

Dr. Clara Höbart


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2021 in Acta Physiologica
Verified
Journal Article
Open access
PDF file
CHClara Höbart
Clara Höbart
NRNatalia S. Rojas‐Galvan
Natalia S. Rojas‐Galvan
CCCosmin Ciotu
Cosmin Ciotu
IAIbrahim Aykac
Ibrahim Aykac
LRLukas Reissig
Lukas Reissig
SHStefan Heber
Stefan Heber
Aim: There is mounting evidence that TRPA1 has a role in cardiac physiology and pathophysiology. We aim to clarify the site of TRPA1 expression in the heart and in particular whether the channel is expressed in cardiomyocytes.Methods: Due to the high calcium conductance of TRPA1, and marginal calcium changes being detectable, microfluorimetry in primary mouse cardiomyocytes, and in the cardiomyocyte cell lines H9c2 and HL‐1, was applied. TRPA1 mRNA in mouse and human hearts, primary cardiomyocytes, and the cardiac cell lines were quantified. Dorsal root ganglia served as control for both methods.Results: In addition to AITC, the more potent and specific TRPA1 agonists JT010 and PF‐4840154 failed to elicit a TRPA1‐mediated response in native and electrically paced primary cardiomyocytes, and the cardiomyocyte cell lines H9c2 and HL‐1. There were only marginal levels of TRPA1 mRNA in cardiomyocytes and cardiac cell lines, also in conditions of cell differentiation or inflammation, which might occur in pathophysiological conditions. Similarly, TRPV1 agonist capsaicin did not activate primary mouse cardiomyocytes, did not alter electrically paced activity in these, and did not activate H9c2 cells or alter spontaneous activity of HL‐1 cells. Human pluripotent stem cells differentiated to cardiomyocytes had no relevant TRPA1 mRNA levels. Also in human post‐mortem heart samples, TRPA1 mRNA levels were substantially lower compared with the respective dorsal root ganglion.Conclusion: The results do not question a role of TRPA1 in the heart but exclude a direct effect in cardiomyocytes.

Verified
Journal Article
Open access
PDF file
CHClara Höbart
Clara Höbart
Attila KissAttila Kiss
Attila Kiss
PPPatrick M. Pilz
Patrick M. Pilz
PSPetra Lujza Szabo
Petra Lujza Szabo
Bruno PodesserBruno Podesser
Bruno Podesser
SHStefan Heber
Stefan Heber
Transient receptor potential cation channel subfamily A member 1 (TRPA1), an ion channel primarily expressed on sensory neurons, can be activated by substances occurring during myocardial infarction. Aims were to investigate whether activation, inhibition, or absence of TRPA1 affects infarcts and to explore underlying mechanisms. In the context of myocardial infarction, rats received a TRPA1 agonist, an antagonist, or vehicle at different time points, and infarct size was assessed. Wild type and TRPA1 knockout mice were also compared in this regard. In vitro, sensory neurons were co-cultured with cardiomyocytes and subjected to a model of ischemia-reperfusion. Although there was a difference between TRPA1 activation or inhibition in vivo, no experimental group was different to control animals in infarct size, which also applies to animals lacking TRPA1. In vitro, survival probability of cardiomyocytes challenged by ischemia-reperfusion increased from 32.8% in absence to 45.1% in presence of sensory neurons, which depends, at least partly, on TRPA1. This study raises doubts about whether TRPA1 is a promising target to reduce myocardial damage within a 24 h period. The results are incompatible with relevant enlargements of infarcts by TRPA1 activation or inhibition, which argues against adverse effects when TRPA1 is targeted for other indications.

15 August 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
CHClara Höbart
Clara Höbart
Attila KissAttila Kiss
Attila Kiss
Bruno PodesserBruno Podesser
Bruno Podesser
Ammar TahirAmmar Tahir
Ammar Tahir
MFMichael J.M. Fischer
Michael J.M. Fischer
SHStefan Heber
Stefan Heber
Sensory neurons densely innervate the myocardium. The role of their sensing and response to acute and prolonged ischemia is largely unclear. In a cellular model of ischemia-reperfusion injury, the presence of sensory neurons increases cardiomyocyte survival. Here, after the exclusion of classical neurotransmitter release, and measurement of cytokine release, we modified the experiment from a direct co-culture of primary murine cardiomyocytes and sensory neurons to a transfer of the supernatant. Sensory neurons were exposed to ischemia and the resulting conditioned supernatant was transferred onto cardiomyocytes. This approach largely increased the tolerance of cardiomyocytes to ischemia and reperfusion. Towards the identification of the mechanism, it was demonstrated that after ten-fold dilution, the conditioned solution lost its protective effect. The effect remained after removal of extracellular vesicles by ultracentrifugation, and was not affected by exposure to protease activity, and fractionation pointed towards a hydrophilic agent. Solutions conditioned by HEK293t cells or 3T3 fibroblasts also increase cardiomyocyte survival, but to a lower degree. A metabolomic search identified 64 at least two-fold changed metabolites and lipids. Many of these could be identified and are involved in essential cellular functions. In the presented model for ischemia-reperfusion, sensory neurons secrete one or more cardioprotective substances that can improve cardiomyocyte survival.

13 October 2026 in Lab on a Chip
Verified
Journal Article
Open access
CHClara Höbart
Clara Höbart
MLManuel Lux
Manuel Lux
SBStanislav Beyl
Stanislav Beyl
BBBozhidar Baltov
Bozhidar Baltov
SHSteffen Hering
Steffen Hering
SphereChip adapts the geometry of spheroids or organoids to a planar MEA surface, stabilises electrode contacts, reduces the influence of contractions on the measurements and allows precise drug applications.